Congress
$1,001–$15,000
Traded Aug 27 · disclosed 16 days laterSits on House Energy and Commerce
4 different filers disclosed JNJ within 90 days.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Aug 17, 2026 · Filed Aug 18, 2026
Johnson & Johnson's WWC. Innovative Medicine sold $3.95M of Johnson & Johnson shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$3,950,400
Shares × reported transaction price
33 days after results of Jul 15, 2026, 57 days before results of Oct 13, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $262.37 on Aug 17, 2026, within 2% of its 52-week high, after a 1% rise over the previous 30 trading days
52-week range $174.16 (Sep 18, 2025) to $267.24 (Jul 7, 2026), 95% of the way up, from 251 adjusted closes. 30 trading days earlier: $259.33 on Jul 6, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Jennifer L Taubert is named in JNJ's executive-change filing of Aug 4, 2026, 13 days before it: "On August 4, 2026, the Company announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee effective September…"
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
FDA approved Imaavy on Aug 24, 2026, 7 days after this trade.
New use approved (efficacy supplement). Active ingredient: Nipocalimab-Aahu. From openFDA. Dates only; no link between the two is implied
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.3% | −0.4% | −0.9% |
| 30 days | −1.3% | −1.0% | −0.3% |
| 90 days | +1.9% | −4.8% | +6.7% |
Past results only. Not a forecast.
Congress
Traded Aug 27 · disclosed 16 days laterSits on House Energy and Commerce
4 different filers disclosed JNJ within 90 days.
Insider filing
Traded Sep 8 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Sep 8 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.